Cancer Research Communications Issues Research Articles in May 2024 Edition
May 22, 2024
May 22, 2024
PHILADELPHIA, Pennsylvania, May 22 -- Cancer Research Communications, a peer-reviewed journal from the American Association for Cancer Research that says it stimulates innovation in cancer science and medicine, published research articles on the following topics in its May 2024 edition (Vol. 4, Issue 5):
* De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression
* LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against . . .
* De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression
* LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against . . .